1 report

  • PACRITINIB - DRUG PROFILE

As of April 2012, it was in Phase II for the treatment of lymphomas (mantle cell lymphoma, Hodgkin lymphoma, indolent lymphoma).

  • Lymphoma
  • Pathology
  • Renal Disease
  • Therapy
  • CTI BioPharma Corp.